A modified trabeculectomy technique with direct filtration into the Tenon's capsule.

IF 4.3 3区材料科学 Q1 ENGINEERING, ELECTRICAL & ELECTRONIC

ACS Applied Electronic Materials Pub Date : 2024-08-22 DOI:10.1016/j.jcjo.2024.08.004

Kaku Itoh, Shohei Suetake, Misaki Negishi, Suguru Murakami, Hiroyasu Katayama, Yurie Omori, Keigo Satoh

{"title":"A modified trabeculectomy technique with direct filtration into the Tenon's capsule.","authors":"Kaku Itoh, Shohei Suetake, Misaki Negishi, Suguru Murakami, Hiroyasu Katayama, Yurie Omori, Keigo Satoh","doi":"10.1016/j.jcjo.2024.08.004","DOIUrl":null,"url":null,"abstract":"Objective: To report the surgical outcomes of a modified trabeculectomy technique involving implanting the Tenon's layer under the scleral flap.Design: Prospective, interventional case series.Participants: 51 eyes with medically uncontrolled glaucoma were enrolled for this study. A new trabeculectomy technique, the Tenon's filtration technique for trabeculectomy (TFT-LEC) was used in 26 eyes, while a conventional procedure, normal trabeculectomy (N-LEC), was used for 25 eyes.Methods: Intraocular pressure (IOP) control, the number of glaucoma medications, the need for additional interventions, and postoperative complications were assessed.Results: Twelve months postoperatively, the mean IOP was 13.5 ± 0.5 mmHg in the TFT-LEC group and 15.4 ± 0.5 mmHg in the N-LEC group (p = 0.13). The TFT-LEC group required an average of 1.3 ± 1.0 additional glaucoma medications (21 cases required only ripasudil) postoperatively, with no cases of bleb needling revision or reoperation. The N-LEC group required an average of 1.7 ± 1.5 glaucoma medications (p = 0.43) compared to TFT-LEC group, eight cases (32%) required bleb needling revision (p = 0.002), and one case (4%) of reoperation (p = 0.49). The complications in the TFT-LEC group included shallow anterior chamber in six (23 %) cases (p = 1.00) compared to N-LEC group, choroidal detachment in two (8%) cases (p = 0.42), and anterior chamber hemorrhage in seven (27%) cases (p = 0.29). None of these complications affected visual function.Conclusions: This new technique involving implanting the Tenon's layer under the scleral flap may improve the postoperative outcomes of trabeculectomy.","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jcjo.2024.08.004","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To report the surgical outcomes of a modified trabeculectomy technique involving implanting the Tenon's layer under the scleral flap.

Design: Prospective, interventional case series.

Participants: 51 eyes with medically uncontrolled glaucoma were enrolled for this study. A new trabeculectomy technique, the Tenon's filtration technique for trabeculectomy (TFT-LEC) was used in 26 eyes, while a conventional procedure, normal trabeculectomy (N-LEC), was used for 25 eyes.

Methods: Intraocular pressure (IOP) control, the number of glaucoma medications, the need for additional interventions, and postoperative complications were assessed.

Results: Twelve months postoperatively, the mean IOP was 13.5 ± 0.5 mmHg in the TFT-LEC group and 15.4 ± 0.5 mmHg in the N-LEC group (p = 0.13). The TFT-LEC group required an average of 1.3 ± 1.0 additional glaucoma medications (21 cases required only ripasudil) postoperatively, with no cases of bleb needling revision or reoperation. The N-LEC group required an average of 1.7 ± 1.5 glaucoma medications (p = 0.43) compared to TFT-LEC group, eight cases (32%) required bleb needling revision (p = 0.002), and one case (4%) of reoperation (p = 0.49). The complications in the TFT-LEC group included shallow anterior chamber in six (23 %) cases (p = 1.00) compared to N-LEC group, choroidal detachment in two (8%) cases (p = 0.42), and anterior chamber hemorrhage in seven (27%) cases (p = 0.29). None of these complications affected visual function.

Conclusions: This new technique involving implanting the Tenon's layer under the scleral flap may improve the postoperative outcomes of trabeculectomy.

查看原文本刊更多论文

改良的小梁切除术，直接在腱膜囊内进行过滤。

目的：报告在巩膜瓣下植入腱膜层的改良小梁切除术的手术效果：报告在巩膜瓣下植入腱膜层的改良小梁切除术的手术效果：前瞻性、介入性病例系列：本研究共招募了 51 例药物无法控制的青光眼患者。26只眼睛采用了新的小梁切除术技术--腱膜滤过小梁切除术（TFT-LEC），25只眼睛采用了传统的小梁切除术（N-LEC）：方法：评估眼压（IOP）控制情况、青光眼用药次数、是否需要额外干预以及术后并发症：术后 12 个月，TFT-LEC 组的平均眼压为 13.5 ± 0.5 mmHg，N-LEC 组为 15.4 ± 0.5 mmHg（P = 0.13）。TFT-LEC 组术后平均需要额外服用 1.3 ± 1.0 种青光眼药物（21 例只需服用利帕苏地），没有眼压计针刺修正或再次手术的病例。与TFT-LEC组相比，N-LEC组平均需要1.7±1.5种青光眼药物（p = 0.43），8例（32%）需要进行眼泡针扎修整（p = 0.002），1例（4%）需要再次手术（p = 0.49）。与 N-LEC 组相比，TFT-LEC 组的并发症包括：6 例（23%）前房变浅（p = 1.00）；2 例（8%）脉络膜脱离（p = 0.42）；7 例（27%）前房出血（p = 0.29）。这些并发症均未影响视功能：这项在巩膜瓣下植入腱膜层的新技术可改善小梁切除术的术后效果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACS Applied Electronic Materials Multiple-

CiteScore

7.20

自引率

4.30%

发文量

567